TrialJournal of inherited metabolic disease2018

A double-blind, placebo-controlled trial of triheptanoin in adult polyglucosan body disease and open-label, long-term outcome.

Raphael Schiffmann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.